Full Fed. Circ. Rejects Bayer Petition In Xarelto Patent Case
The full Federal Circuit on Monday declined a petition from German pharmaceutical giant Bayer asking the appeals court to take a look at reviving patent claims related to its blood thinner medication Xarelto....To view the full article, register now.
Already a subscriber? Click here to view full article